Drug interactions between bevacizumab and erlotinib
Interactions between your drugs
There were no interactions found in our database between bevacizumab and erlotinib - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
- Bevacizumab is in the drug class VEGF/VEGFR inhibitors.
- Bevacizumab is used to treat the following conditions:
- Erlotinib is a member of the drug class EGFR inhibitors.
- Erlotinib is used to treat the following conditions:
Drug and food interactions
Applies to: erlotinib
Erlotinib should be taken on an empty stomach 1 hour before or 2 hours after a meal and at the same time each day unless otherwise directed by your doctor. You should also avoid grapefruit and grapefruit juice while taking erlotinib. Food and grapefruit can raise the levels of erlotinib in your body and lead to increased side effects. Do not increase or decrease the amount of grapefruit products in your diet without first talking to your doctor.
Therapeutic duplication warnings
No therapeutic duplications were found for your selected drugs.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.